TP53 and diffuse large B-cell lymphoma: By analyzing the positron emission tomography/computed tomography parameters and next‐generation sequencing of primary DLBCL patients in the training cohort and validation cohort, we found the nomogram based on imaging factors and TP53 status could lead to a more accurate selection of DLBCL patients with rapid progression, to increase tailor therapy.